International collaborative phase III trial of adjuvant zoledronic acid to reduce recurrence in patients with localised breast cancer (VCOG BR 2-03)

Lead researcher

Associate Professor Richard Bell, Deborah Howell, VCOG Breast Cancer Committee

The Alfred, Austin Health, Ballarat Oncology and Haematology Services, Barwon Health, Border Medical Oncology, Box Hill Hospital, Freemasons Hospital, Maroondah Hospital, Mercy Private Hospital, Monash Medical Centre, Peninsula Health, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, St John of God Geelong, St Vincent's Health, Western Hospital and 14 other sites in Australia and Thailand

Years funded

197 patients were recruited from Australia and Thailand in 2005 (Australian target 240 patients, international target 3300).